Search the Newsreel

Civeo Corporation Q2 2026 Earnings Call Summary

Civeo Corporation Q2 2026 Earnings Call Summary - Moby Strategic Performance and Market Dynamics Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here. …

Civeo Corporation (NYSE: CVEO) lifts H1 2026 revenue 15% but stays in loss

Civeo Corporation (NYSE: CVEO) reported a 15% increase in first-half 2026 revenue to $352.68 million, primarily driven by new integrated services contracts, an acquisition, and currency tailwinds. Despite the revenue growth and narrowing net loss to $6.33 million, the company remained unprofitable. Key financial …

Earnings call transcript: Civeo tops Q2 2026 estimates as shares slip premarket

Civeo Corporation reported better-than-expected Q2 2026 results with a smaller loss and higher revenue, yet its shares declined premarket due to softer adjusted EBITDA, temporary Australian cost pressures, and start-up costs for a new Ontario contract. Despite beating analyst estimates and maintaining full-year guidance, …

BlackRock (UNCY holder) reports 5.3% Unicycive Therapeutics stake in Schedule 13G

BlackRock, Inc. has filed a Schedule 13G, disclosing a passive ownership stake of 5.3% in Unicycive Therapeutics, Inc. This stake amounts to 1,413,381 shares of common stock, with BlackRock holding sole voting power over 1,391,049 shares and sole dispositive power over all 1,413,381 shares. …

CVEO Archives

This page provides an archive of news and articles related to Civeo Corp (CVEO), a company specializing in hospitality services for the natural resource industry. It highlights Civeo's recent Q2 2026 financial results, where the company missed EPS estimates but beat revenue expectations, and …

Civeo Corporation (NYSE: CVEO) Q2 2026, $115M convert and buyback

Civeo Corporation reported its Q2 2026 financial results, with revenues of $180.0 million and a net loss of $2.5 million, an improvement from the previous year. The company also announced the issuance of $115.0 million in 4.50% convertible senior notes due 2031 and a …

Unicycive Therapeutics Inc Today's Market Trends | UNCY Stock Real-Time Quotes, Trading Strategies & Related Analysis | TradingKey

Unicycive Therapeutics Inc (UNCY) is a biotechnology company focused on kidney disease treatments, with lead drug candidate oxylanthanum carbonate (OLC) and UNI-494 in development. Despite strong fundamentals and significant institutional ownership, the stock has shown weak market performance and is currently trading sideways. Analysts, …

Civeo (CVEO) Earnings Date and Reports 2026

Civeo (CVEO) Reports Q2 Loss, Tops Revenue Estimates

Civeo (CVEO) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.3. This compares to a loss of $0.25 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report …

CIVB|Civista Bancshares Inc|Price:29.250|Chg%:-0.050

This article provides a comprehensive stock analysis of Civista Bancshares Inc (CIVB) by TradingKey. It highlights the company's strong fundamentals and high growth potential, classifying its valuation as fairly valued within the banking services industry. The analysis also notes high institutional ownership and a …

Civeo Corp (CVEO) Financial Health: Profitability & Balance Sheet Analysis

Civeo Corp (CVEO) currently holds a financial score of 7.17, placing it 8th out of 46 in the Real Estate Operations industry. The company's financial status is stable, though its operating efficiency is noted as low. In its latest quarter, Civeo Corp reported a …

Civista Bancshares (CIVB) director returns 57.6500 shares to the issuer

Civista Bancshares director Mark J. Macioce returned 57.6500 shares of common stock to the issuer on July 29, 2026, at a price of $29.4850 per share. This disposition-to-issuer transaction was not made under a Rule 10b5-1 trading plan, and no derivative positions were reported. …

Court-Appointed Monitor Finds California ICE Facility Failed All Basic Medical Care Standards

A court-appointed medical monitor reported that the California City Detention Facility, the largest ICE detention center in California, failed to meet all eight core standards for a functioning healthcare system, exposing detainees to "serious risk." The investigation, ordered by a U.S. District Judge following …

Civista Bancshares Inc (CIVB) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article from TradingKey provides a revenue breakdown for Civista Bancshares Inc (CIVB), detailing its business segments, regional revenue, and profit contribution. However, the article explicitly states that relevant data for these categories have not been disclosed by the company yet. It serves more …

Civista Bancshares (CIVB) Stock Sees Fair Value Lift After Analysts Raise Targets

How Civista Bancshares Inc. (CIVB) Affects Rotational Strategy Timing

This article analyzes Civista Bancshares Inc. (CIVB) using AI models to provide trading strategies for various risk profiles. It identifies a current breakout with potential for higher levels due to no remaining resistance and suggests neutral sentiment in the near and mid-term, but a …

CoreCivic Inc (CXW) Institutional Confidence

CoreCivic Inc (CXW) received an institutional shareholding score of 10.00, placing it first in its industry. The institutional shareholding proportion decreased by 7.82% quarter-over-quarter to 92.50%. ETHSX is the largest institutional shareholder, holding 335.06K shares.

CoreCivic: Time To Take Profits And De-Risk (Rating Downgrade) (NYSE:CXW)

The author, Danilo Drocco, is downgrading CoreCivic (CXW) to a "sell" after previously maintaining a bullish stance due to significant returns. The decision is based on a change in government strategy which makes the stock too risky, and inflated valuations leading to an unfavorable …

Unicycive Therapeutics (UNCY) grants 47,941 RSUs to director Laumas

Unicycive Therapeutics director Sandeep Laumas was granted 47,941 restricted stock units (RSUs) on May 14, 2026, as reported in a Form 4/A filing. Of these, 19,976 RSUs vested upon grant, and the remaining 3,995 units will vest monthly over seven months, subject to his …

Unicycive Therapeutics (UNCY) director granted 47,941 RSUs with staged vesting

Unicycive Therapeutics director Sara Kenkare-Mitra was granted 47,941 Restricted Stock Units (RSUs) on May 14, 2026. Of these, 19,976 shares vested immediately, and the remaining 3,995 shares will vest monthly over seven months, starting June 1, 2026, contingent upon her continued service. The transaction, …

CXW|CoreCivic Inc|Price:30.620|Chg%:-0.590

CoreCivic Inc (CXW) fundamentals are strong, with high growth potential and fair valuation, ranking 38th in its industry. Analysts rate it as "Buy" with a 21.76% upside target of $38.00. Despite very high institutional ownership, there was a 10.43% decrease in institutional holdings quarter-over-quarter.

Unicycive Therapeutics Inc (UNCY) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis for Unicycive Therapeutics Inc (UNCY), noting its current valuation score of 6.30, which ranks 341 out of 386 in the Biotechnology & Medical Research industry. The company's current P/E ratio is -2.28, significantly below its recent high. Key …

Unicycive Therapeutics, Inc. Revenue Breakdown – NASDAQ:UNCY

This page provides financial information for Unicycive Therapeutics, Inc. (UNCY) on the Nasdaq Stock Market. It offers an overview of the company's financials, including statements, statistics, dividends, earnings, and segment breakdown options. The content itself seems to be a template for financial data presentation …

CoreCivic Inc (CXW) Cash Flow

This article provides a detailed cash flow statement for CoreCivic Inc (CXW), covering annual and quarterly data across operating, investing, and financing activities. It presents financial figures and year-over-year changes for various cash flow components, allowing users to assess the company's financial health. The …

Weiss Asset Management LP Purchases Shares of 106,560 CoreCivic, Inc. $CXW

Weiss Asset Management LP acquired 106,560 shares of CoreCivic, Inc. (CXW) in the first quarter, valued at approximately $2.0 million, representing a 0.11% stake in the company. Institutional investors collectively own 85.13% of CoreCivic, a real estate investment trust specializing in correctional and detention …

Mendon Capital Advisors Corp Acquires 86,390 Shares of Civista Bancshares, Inc. $CIVB

Mendon Capital Advisors Corp significantly increased its stake in Civista Bancshares, Inc. (NASDAQ:CIVB) by 38.3% in the first quarter, adding 86,390 shares to its portfolio, now holding 311,725 shares valued at approximately $7.1 million. This increase makes Civista Bancshares the 15th largest holding for …

Civeo Corporation $CVEO Shares Sold by Flat Footed LLC

Flat Footed LLC significantly reduced its stake in Civeo Corporation (NYSE:CVEO) in the first quarter of 2026, selling 115,518 shares and retaining 347,240 worth approximately $9.2 million. Despite this, other institutional investors increased their holdings, and Civeo's shares opened near their 52-week high after …

Civeo Corp (CVEO) Cash Flow

This article provides a detailed historical cash flow statement for Civeo Corp (CVEO), including quarterly and annual data for operating, investing, and financing activities. It breaks down various components such as net income, capital expenditures, and changes in working capital. The piece also includes …

CVEO|Civeo Corp|Price:35.930|Chg%:+1.260

This article provides a detailed financial overview of Civeo Corp (CVEO), including its stock performance, market capitalization, and key financial statements such as the income statement, balance sheet, and cash flow statement. It highlights the company's latest earnings report, showing an EPS forecast of …

DA Davidson Forecasts Strong Price Appreciation for Civista Bancshares (NASDAQ:CIVB) Stock

Unicycive Therapeutics Inc (UNCY) Cash Flow

This article provides a detailed look at Unicycive Therapeutics Inc's (UNCY) cash flow statements, including operating, investing, and financing activities, spanning from FY2019Q4 to FY2026Q1. It presents quarterly and annual financial data, highlighting changes in net income, working capital, capital expenditures, and cash balances …

Civista Bancshares Inc (CIVB) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Civista Bancshares Inc (CIVB), providing a breakdown of major shareholders, institutional holdings, and shareholder types. Key institutional investors like Wellington Management Company, BlackRock, and AllianceBernstein L.P. are highlighted, along with their respective proportions and changes in holdings. …

Civista Bancshares Inc (CIVB) Q1 2026 Earnings Report - Results, Call & Slides

Civista Bancshares Inc (CIVB) reported strong Q1 2026 earnings, beating analyst expectations for both EPS and revenue. The company announced actual EPS of $0.74 against a consensus of $0.57 and actual revenue of $65.24 million compared to an expected $45.52 million. CIVB's revenue also …

Globe Civil Projects Ltd. Revenue Breakdown – NSE:GLOBECIVIL

CoreCivic Inc (CXW) Earnings Forecast: Future EPS & Revenue Growth Estimates

CoreCivic Inc (CXW) currently has an earnings forecast score of 8.00, placing it 33rd in the Professional & Commercial Services industry. Analysts project a price target of $29.50, with a consensus "Buy" rating based on 4 analyst opinions. The company's expected revenue for the …

Cooper Creek Partners Management LLC Reduces Stock Holdings in CoreCivic, Inc. $CXW

Cooper Creek Partners Management LLC significantly reduced its stake in CoreCivic, Inc. by 51.7% in the first quarter, selling over 3 million shares and ending with 2.85 million shares valued at approximately $53.9 million. Despite this reduction, other institutional investors like Royal Bank of …